Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy

被引：0
|
作者：
S. Lautenschlaeger
C. Dumke
L. Exeli
H. Hauswald
R. Engenhart-Cabillic
F. Eberle
机构：
[1] Universitätsklinikum Marburg,Klinik für Strahlentherapie und Radioonkologie
[2] Marburg Ion-Beam Therapy Center (MIT),RNS Gemeinschaftspraxis
[3] St. Josefs-Hospital,Klinik für Radio
[4] Universitätsklinikum Heidelberg,Onkologie
来源：
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词：
Radioresistant cancer; Salvage chemoradiation; Particle beam radiotherapy; RBE; Gastrointestinal cancers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：982 / 991
页数：9
相关论文
共 50 条
  • [1] Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy
    Lautenschlaeger, S.
    Dumke, C.
    Exeli, L.
    Hauswald, H.
    Engenhart-Cabillic, R.
    Eberle, F.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (11) : 982 - 991
  • [2] Gemcitabine-based combinations in non resectable pancreatic adenocarcinoma
    Louvet, C
    André, T
    Artru, P
    [J]. BULLETIN DU CANCER, 2002, 89 : S96 - S101
  • [3] Treatment of metastatic and/or unresectable pancreatic cancer with gemcitabine-based chemotherapy
    Samelis, GF
    Zografos, G
    Areovimata, A
    Kitsou, V
    Papakostas, P
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324
  • [4] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [5] Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
    Takahashi, Hidenori
    Ohigashi, Hiroaki
    Gotoh, Kunihito
    Marubashi, Shigeru
    Yamada, Terumasa
    Murata, Masayuki
    Ioka, Tatsuya
    Uehara, Hiroyuki
    Yano, Masahiko
    Ishikawa, Osamu
    [J]. ANNALS OF SURGERY, 2013, 258 (06) : 1040 - 1050
  • [6] Preoperative Gemcitabine-based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer Reply
    Takahashi, Hidenori
    Ishikawa, Osamu
    [J]. ANNALS OF SURGERY, 2015, 262 (06) : E103 - E104
  • [7] Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer
    Chabot, John A.
    Tsai, Wei-Yann
    Fine, Robert L.
    Chen, Chunxia
    Kumah, Carolyn K.
    Antman, Karen A.
    Grann, Victor R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2058 - 2063
  • [8] Gemcitabine-based combination treatment of pancreatic cancer
    Heinemann, V
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 25 - 35
  • [9] A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients
    Yanagimoto, Hiroaki
    Shiomi, Hisanori
    Satoi, Sohei
    Mine, Takashi
    Toyokawa, Hideyoshi
    Yamamoto, Tomohisa
    Tani, Tohru
    Yamada, Akira
    Kwon, A-Hon
    Komatsu, Nobukazu
    Itoh, Kyogo
    Noguchi, Masanori
    [J]. ONCOLOGY REPORTS, 2010, 24 (03) : 795 - 801
  • [10] Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer
    Tajima, Hidehiro
    Ohta, Tetsuo
    Okazaki, Mitsuyoshi
    Yamaguchi, Takahisa
    Ohbatake, Yoshinao
    Okamoto, Koichi
    Nakanuma, Shinichi
    Kinoshita, Jun
    Makino, Isamu
    Nakamura, Keishi
    Miyashita, Tomoharu
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Fushida, Sachio
    Nakamura, Hiroyuki
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (02) : 157 - 166
12345